earnings
confidence high
sentiment negative
materiality 0.70
Treace Medical Q4 revenue $62.5M (-9% YoY); guides FY2026 revenue down 0-6%
TREACE MEDICAL CONCEPTS, INC.
2025-FY EPS reported
-$0.93
revenue$212,690,000
- Q4 revenue $62.5M, down 9% YoY; net loss $(9.4)M vs $(0.5)M in prior year.
- FY2025 revenue $212.7M, up 2% YoY; net loss $(59.0)M vs $(55.7)M; adj. EBITDA loss $(3.9)M.
- Guidance: FY2026 revenue $200-212M (decline 0-6%); adj. EBITDA loss $4-6M.
- Cash used fell 46% to $27.3M in FY2025; active surgeons +6% to 3,337.